
stockNASDAQ: BIIB • 3 Months Updates
Biogen Stock (BIIB) 3 Months
Showing Closing Date Range from Aug 1 to Oct 30, 2026.
Biogen is a biotechnology pioneer discovering and developing therapies for neurological and neurodegenerative diseases.
Investor Relations:biogen.com
Price & Performance Trajectory
Biogen Inc.NASDAQ: BIIB
Latest Close
$253.62
3 Months Updates Trajectory
Showing Closing Date Range from Aug 1 to Oct 30, 2026.Loading trajectory chart...
Click metric scorecards below to toggle price, return %, range & volume curvesBIIB session performance
✓ Latest Close USD
$253.62
Latest session close
+$51.8vs period start
Period Return % % GAIN
+25.67%
Net period trajectory
Cumulative ReturnNormalized
High / Low Range SPREAD
$258.73 / $199.58
Period range envelope
$59.15channel spread
Total Volume SHARES
65.26M
Period turnover
Avg: 1.04M/dLiquidity
Historical Session Ledger
Daily open, high, low, and close prices with volume and period returns.
Historical Quotes & Breakdown(63 dates)
| Date | Close (USD) | Return % | High | Low | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $253.62 | +1.59% | $258.73 | $251.19 | 1.30M |
| Oct 29, 2026 | $249.65 | +2.29% | $255.55 | $246.48 | 1.14M |
| Oct 28, 2026 | $244.05 | -3.43% | $258.63 | $243.03 | 2.32M |
| Oct 27, 2026 | $252.73 | +0.19% | $253.98 | $248.46 | 1.19M |
| Oct 26, 2026 | $252.26 | +0.63% | $254.00 | $249.61 | 958.8K |
| Oct 23, 2026 | $250.69 | -1.24% | $252.44 | $246.15 | 1.15M |
| Oct 22, 2026 | $253.84 | +5.34% | $254.39 | $240.05 | 2.24M |
| Oct 21, 2026 | $240.98 | -0.87% | $243.32 | $240.15 | 812.8K |
| Oct 20, 2026 | $243.10 | +4.12% | $244.65 | $236.24 | 1.49M |
| Oct 19, 2026 | $233.48 | +0.36% | $236.00 | $231.04 | 949.4K |
| Oct 16, 2026 | $232.65 | -1.15% | $236.74 | $232.46 | 1.46M |
| Oct 15, 2026 | $235.35 | +1.08% | $240.99 | $235.22 | 1.57M |
| Oct 14, 2026 | $232.83 | +1.72% | $234.20 | $228.00 | 1.86M |
| Oct 13, 2026 | $228.90 | -0.22% | $231.04 | $226.71 | 1.05M |
| Oct 12, 2026 | $229.41 | +1.64% | $238.24 | $229.00 | 1.46M |
Page 1 of 5